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AUTHORIZES BONDS CONTINUING
STEM CELL RESEARCH.
INITIATIVE STATUTE.

OFFICIAL TITLE AND SUMMARY

PREPARED BY THE ATTORNEY GENERAL

The text of this measure can be found on page 89 and the Secretary of State’s website at
voterguide.sos.ca.gov.
• Authorizes $5.5 billion in state general
obligation bonds to fund grants from
the California Institute of Regenerative
Medicine to educational, nonproﬁt, and
private entities for: stem cell and other
medical research, including training; stem
cell therapy development and delivery;
research facility construction; and
associated administrative expenses.
• Dedicates $1.5 billion to research and
therapy for Alzheimer’s, Parkinson’s,
stroke, epilepsy, and other brain and
central nervous system diseases and
conditions.
• Appropriates General Fund moneys to pay
bond debt service.
• Expands programs promoting stem cell
and other medical research, therapy
development and delivery, and student and
physician training and fellowships.

SUMMARY OF LEGISLATIVE ANALYST’S ESTIMATE
OF NET STATE AND LOCAL GOVERNMENT
FISCAL IMPACT:
• Increased state costs to repay bonds
estimated at about $260 million per year
over the next roughly 30 years.

Summary of State Costs
New Borrowing
Principal
Interest
Total Estimated Cost
Payments
Average annual cost
Assumed payment period
Source of payments

$5.5 billion
2.3 billion
$7.8 billion
$260 million
30 years
Primarily General Fund
tax revenue

ANALYSIS BY THE LEGISLATIVE ANALYST

BACKGROUND
Researchers Use Stem Cells to Study and
Treat Many Diseases. Stem cells are certain
types of cells that exist within humans.
Researchers are interested in stem cells for
their potential to regenerate cells, tissues,
and organs, thereby potentially helping to
treat or cure certain diseases. Researchers
engaged in “regenerative medicine” are
focused on addressing many diseases,
including Alzheimer’s disease, HIV/AIDS,
stroke, diabetes, and cancer.
Voters Approved Earlier Stem Cell Ballot
Measure. In 2004, voters approved
Proposition 71, which added a provision to
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the State Constitution afﬁrming the right of
researchers in California to conduct stem
cell research. The measure also created
the California Institute for Regenerative
Medicine (CIRM), primarily for the purpose
of providing grants to universities and other
entities in California to support stem cell
research, development of new treatments,
clinical trials, new research facilities,
and other related activities. The measure
also established (1) a governing board to
adopt CIRM policies and allocate grant
funds, (2) three advisory working groups to
help guide the governing board on certain
matters, and (3) an independent oversight
committee to review CIRM’s ﬁnances.
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Measure Allowed State to Issue General
Obligation Bonds. Proposition 71 allowed the
state to sell $3 billion in general obligation
bonds, which are a form of borrowing. The
state sold the bonds to investors, and the
money generated from these sales funded
CIRM grants and operations. After selling
bonds, the state has been repaying investors
with interest over many years. As is typically
the case with these kinds of bonds, the state
has made most debt payments from the
General Fund—the state’s main operating
account, which pays for education, prisons,
health care, and other public services. The
measure required that a small amount of
interest be paid by funds from the bond
sales. (For more information on the state’s
use of bonds, see “Overview of State Bond
Debt” later in this guide.)

Grants Have Funded Several Purposes.
Figure 1 shows how CIRM has used its grant
funding. Funded projects have involved
conducting basic science research (such
as laboratory research on stem cells),
developing potential treatments, and
undertaking clinical trials. Grant funds also
have supported other activities, including
construction of new research facilities and
research internships for college students.
The University of California has received
the greatest amount of grant funding,
followed by private nonproﬁt universities and
institutions (such as Stanford University).
In addition to receiving a grant from CIRM,
many grant recipients receive additional
funding from other sources for their projects.
Other common fund sources are industry

Figure 1

Summary of Proposition 71 Stem Cell Grants
$2.7 Billion Awarded Since 2004
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contributions, private donations, and federal
grants.
Grant Recipients Are Required to Share
Invention-Related Income With the State.
Some stem cell research can lead to
new inventions, including new medical
technologies and treatments. Proposition 71
required grant recipients who license or sell
their inventions to share a portion of the
resulting income with the state. The state’s
share of the income is deposited into the
General Fund and may be used to support
any state program. Over the years, CIRM’s
governing board has developed rules for how
income revenue is shared with the state.
The state began receiving income from
CIRM-funded inventions in 2017. To date,
these inventions have provided a total of
approximately $350,000 to the state.
CIRM Has Spent Nearly All Available Funds. As
of June 2020, CIRM had spent most of its
Proposition 71 funds. According to CIRM,
around $30 million remains available for
grants. As it nears the end of its funding,
CIRM has been decreasing its stafﬁng. The
institute currently employs 35 full-time
staff, down from its peak of over 50 full-time
staff. It plans to maintain some staff for the
next few years as remaining projects are
completed.

PROPOSAL
Authorizes New Bonds for Stem Cell Activities.
Proposition 14 allows the state to sell
$5.5 billion in general obligation bonds. The
bonds primarily would fund additional grants
to support research and the development
of treatments (including clinical trials) for
many diseases. The proposition sets aside at
least $1.5 billion speciﬁcally to research and
develop treatments for diseases affecting
the brain and central nervous system (such
18 | Analysis
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as Alzheimer’s disease and Parkinson’s
disease). The proposition directs CIRM to
allocate a small share of grant funding for
training opportunities for students at the
California State University and the California
Community Colleges, as well as a small
share for helping to establish and support
facilities focused on research and clinical
trials. For some types of grants, CIRM
would be required to ensure grant recipients
are located across the state and prioritize
applicants that offer matching funds. The
proposition allows CIRM to spend no more
than 7.5 percent of bond funds on its
administrative costs.
Establishes Certain Rules Relating to the Bonds.
The proposition limits the amount of bonds
the state could sell to $540 million per year,
thereby spreading out bond sales over at
least 11 years. For the ﬁrst ﬁve years after
the proposition is approved, the state would
make interest payments using funds from the
bond sales, thereby reducing the amount of
bond funding available for research projects.
Beginning January 1, 2026, the state would
no longer use funds from bond sales to make
interest payments. Instead, the state would
make remaining debt payments from the
General Fund.
Makes Numerous Changes to CIRM. Most
notably, the proposition makes several
changes intended to improve patient access
to stem cell treatments. The proposition
allows CIRM to hire up to 15 full-time
employees speciﬁcally for developing policies
and programs relating to improving access to
and affordability of treatments for patients.
(The institute would be allowed up to
70 full-time employees for other operational
purposes.) A new advisory working group
of experts would support CIRM’s governing
board in these matters. Further, any

AUTHORIZES BONDS CONTINUING
STEM CELL RESEARCH.
INITIATIVE STATUTE.

ANALYSIS BY THE LEGISLATIVE ANALYST

invention-related revenue that is deposited
into the General Fund would be used to
help pay for patients’ regenerative medicine
treatments. Among various other changes,
the proposition also increases the number of
members on CIRM’s governing board from
29 to 35.

FISCAL EFFECTS
Total Estimated State Costs of $7.8 Billion. The
cost to repay the bonds authorized by this
proposition depends on various factors, such
as the interest rates on the bonds and the
time period over which they are repaid. We
estimate the total cost to pay off the bonds
would be $7.8 billion—$5.5 billion for the
principal and $2.3 billion for the interest.
State costs would average about $260 million
per year for about 30 years. This amount is
less than 1 percent of the state’s current
General Fund budget.
Difﬁcult to Estimate Invention-Related Income
Available for Patients’ Treatment Costs. The
amount of revenue from new inventions that
would be available to the state for helping
to cover costs for patients’ regenerative
medicine treatments is uncertain. Many
times, research does not lead to an
invention. Also, a signiﬁcant amount of time

For the full text of Proposition 14, see page 89.
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typically passes from starting a research
project to licensing or selling an associated
invention. To date, the state has collected a
few hundred thousand dollars in inventionrelated income. Past revenue collections,
however, might not accurately predict future
revenue.
Other Possible Fiscal Effects. The proposition
could result in numerous indirect effects on
state and local governments. For example,
if the proposition were to result in new
treatments, state and local government costs
for some programs such as Medi-Cal, the
state’s subsidized health care program for
low-income people, could be affected. The
net ﬁscal impact of the indirect effects of
this proposition is unknown.

Visit http://cal-access.sos.ca.gov/campaign/
measures/ for a list of committees primarily
formed to support or oppose this measure.
Visit http://www.fppc.ca.gov/
transparency/top-contributors.html
to access the committee’s top 10 contributors.
A copy of the full text of this state measure
can be found on page 89 of this guide.
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